Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS  |  Issue: May 2014  |  May 1, 2014

At age 28, she presented with hypertensive urgency and intestinal angina and was found to have renal artery stenosis. Magnetic resonance angiography (MRA) at that time revealed evidence of a large-vessel vasculitis of the abdominal aorta near the renal arteries, as well as the superior mesenteric artery, and she was diagnosed with Takayasu’s arteritis.

She was treated with high-dose glucocorticoids, azathioprine and infliximab infusions of 5 mg/kg every eight weeks. During tapering of her prednisone dose, she developed abdominal pain suggestive of intestinal ischemia. The dose and frequency of infliximab infusions were increased to 5 mg/kg every six weeks. On this regimen, she was able to taper off prednisone and then, four months prior to admission, to taper off azathioprine.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

One month prior to admission she again developed postprandial abdominal pain, which improved after a short course of prednisone. The week prior to admission, the patient developed worsening headache and frothy urine, and she was found to have a blood pressure of 175/104 mmHg in the right arm at her infusion visit. She denied fevers, chills, weight loss, abdominal pain, arm or leg claudication, rash or other new symptoms.

On admission to the hospital, her blood pressure was 200/108 mmHg with no remarkable differences between all four extremities. ESR was 35 mm/hr, compared to a baseline of 7 mm/hr. Her complete blood count was unremarkable. Potassium was 5.1 mmol/L with a creatinine of 3.95 mg/dL. Urinalysis revealed an absence of red and white blood cells, and a urine protein to creatinine ratio was 0.47. Renin activity and aldosterone were both elevated at 52 pg/mL and 46.6 ng/dL respectively with a normal ratio, suggestive of renovascular disease. Duplex ultrasound was a limited study showing decreased flow in the right kidney, which appeared atrophic. Flow velocities were elevated in the left renal artery. An MRA without gadolinium revealed wall thickening of the abdominal aorta most prominent at the level of the superior mesenteric artery (SMA) extending to below the location of the renal arteries with wall thickening of the proximal SMA and left renal artery (see Figure 3). The right renal artery was diminutive with atrophy of the right kidney, similar to studies in 2011.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The American College of Rheumatology 1990 Criteria for the Classification of Takayasu’s Arteritis
click for large version
Table 1: The American College of Rheumatology 1990 Criteria for the Classification of Takayasu’s Arteritis

Lisinopril was discontinued, and 1 g of methylprednisolone was administered intravenously for three consecutive days. Her creatinine rose to a peak of

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:drugGiant Cell ArteritisGlucocorticoidsimaginginfliximablarge-vessel vasculitisMethotrexatePainpatient careprednisonerheumatologistrituximabTakayasu’s ArteritistocilizumabTreatmentVasculitis

Related Articles

    Fellow’s Forum Case Report: Aneurysm in Takayasu’s Arteritis

    August 17, 2015

    A healthy 30-year-old Indian male was performing his routine workout in the gym when he developed giddiness and transient blackouts. He thought it was due to exercising excessively. Over the next month, he developed a low-grade fever and started feeling lethargic, to the extent that he was unable to exercise or work. He was admitted…

    Study Finds Tocilizumab Could Be Treatment Option for Takayasu Arteritis

    August 17, 2018

    For patients with refractory Takayasu arteritis (TAK), glucocorticoids (GCs) are often provided as the initial therapy for treatment. However, GCs are often associated with adverse effects for long-term use; relapse also occurs frequently during GC tapering.1 TAK involves interleukin (IL) 6. Tocilizumab—a recombinant, humanized, anti-IL-6 receptor (IL-6R) monoclonal antibody—was first reported by Nishimoto et al….

    Patients with Large-Vessel Abnormalities Present Diagnostic Dilemma for Rheumatologists

    February 1, 2015

    Absent signs, symptoms suggesting etiology, clinicians rely on inflammatory markers, imaging to make the diagnosis

    Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

    March 1, 2013

    Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences